CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)

CUSIP: G1933S101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Ordinary Shares
Shares outstanding
35,821,764
Total 13F shares
100
Share change
+100
Total reported value
$179
Price per share
$1.79
Number of holders
1
Value change
+$179
Number of buys
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q4 2022

As of 31 Dec 2022, CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 100 shares. The largest 1 holders included WEST PACES ADVISORS INC.. This page lists 1 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2025 Across Filers

Q3 2025 holders
21
Q4 2022 holders
1
Holder diff
-20
Investor Q3 2025 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.